Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Bioinformatics (Oxford, England)|September 28, 2010
Identification of context-dependent motifs by contrasting ChIP binding dataMike J Mason, Kathrin Plath, Qing ZhouBMC Genomics|July 22, 2009
Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cellsMike J Mason, Guoping Fan, Kathrin Plath, et al.Cell|January 27, 2009
Role of the murine reprogramming factors in the induction of pluripotencyRupa Sridharan, Jason Tchieu, Mike J Mason, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal CancerNeeraj Lal, Brian S White, Ghaleb Goussous, et al.Nature|July 10, 2009
Chd1 regulates open chromatin and pluripotency of embryonic stem cellsAlexandre Gaspar-Maia, Adi Alajem, Fanny Polesso, et al.Diabetes|January 17, 2014
Low HERV-K(C4) copy number is associated with type 1 diabetesMike J Mason, Cate Speake, Vivian H Gersuk, et al.NPJ Precision Oncology|June 29, 2021
Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myelomaMatthew A Wall, Serdar Turkarslan, Wei-Ju Wu, et al.NPJ Precision Oncology|July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemiaBrian S White, Suleiman A Khan, Mike J Mason, et al.Cell Stem Cell|July 3, 2009
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signaturesMark H Chin, Mike J Mason, Wei Xie, et al.Nature Communications|June 19, 2019
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screenMichael P Menden, Dennis Wang, Mike J Mason, et al.Pageof 2